Golimumab

Next

Simponi® ,

Golimumab

Disease
Ulcerative colitis ,
Drug Class
Biologics/Biosimilars
Delivery Method
Injection or
Brand name:
Simponi® ,
Drug name:
Golimumab
Drug type
Anti-TNF
Recommendations for pregnancy

No proven risk in humans

Recommendations for breastfeeding

No human data: probably compatible

Most common side effects

Upper respiratory infection such as runny nose, sore throat, hoarseness or laryngitis; injection site reactions such as redness, swelling, itching, pain, bruising and tingling; viral infections such as flu and oral cold sores.

Other

There are reports of serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. To see the full prescribing information for this medication, click here.

Learn more about Biologics/Biosimilars

Golimumab

Video Length

Golimumab